INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $97,828 | -46.4% | 119,302 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $182,408 | -9.7% | 116,928 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $202,000 | +13.5% | 117,353 | +14.1% | 0.00% | 0.0% |
| Q2 2022 | $178,000 | -51.8% | 102,881 | +0.2% | 0.00% | -50.0% |
| Q1 2022 | $369,000 | -32.7% | 102,655 | -6.6% | 0.00% | -33.3% |
| Q4 2021 | $548,000 | -32.3% | 109,880 | -2.9% | 0.00% | -25.0% |
| Q3 2021 | $810,000 | -24.6% | 113,168 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $1,074,000 | +7.2% | 115,857 | +7.3% | 0.00% | 0.0% |
| Q1 2021 | $1,002,000 | +22.8% | 107,944 | +17.1% | 0.00% | +33.3% |
| Q4 2020 | $816,000 | -25.0% | 92,167 | -1.7% | 0.00% | -40.0% |
| Q3 2020 | $1,088,000 | -54.1% | 93,755 | +6.6% | 0.01% | -54.5% |
| Q2 2020 | $2,371,000 | +467.2% | 87,989 | +56.7% | 0.01% | +450.0% |
| Q1 2020 | $418,000 | +117.7% | 56,169 | -3.2% | 0.00% | +100.0% |
| Q4 2019 | $192,000 | +60.0% | 58,047 | -0.8% | 0.00% | – |
| Q3 2019 | $120,000 | -30.2% | 58,536 | +0.3% | 0.00% | -100.0% |
| Q2 2019 | $172,000 | -16.9% | 58,352 | +5.3% | 0.00% | 0.0% |
| Q1 2019 | $207,000 | -5.0% | 55,425 | +1.5% | 0.00% | 0.0% |
| Q4 2018 | $218,000 | -28.8% | 54,589 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $306,000 | +44.3% | 55,009 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $212,000 | -13.5% | 54,017 | +3.7% | 0.00% | 0.0% |
| Q1 2018 | $245,000 | +7.9% | 52,073 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $227,000 | -33.6% | 54,874 | +1.7% | 0.00% | 0.0% |
| Q3 2017 | $342,000 | +4.3% | 53,963 | +29.1% | 0.00% | 0.0% |
| Q2 2017 | $328,000 | +21.5% | 41,794 | +2.3% | 0.00% | 0.0% |
| Q1 2017 | $270,000 | +1.9% | 40,856 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $265,000 | -99.9% | 38,161 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $356,583,000 | +1.0% | 38,260 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $352,986,000 | -8.1% | 38,202 | -13.3% | 0.00% | -50.0% |
| Q1 2016 | $384,000,000 | +25.5% | 44,062 | -2.8% | 0.00% | +100.0% |
| Q4 2015 | $306,000,000 | +87079.5% | 45,328 | -25.3% | 0.00% | -50.0% |
| Q3 2015 | $351,000 | -99.9% | 60,647 | +0.9% | 0.00% | 0.0% |
| Q2 2015 | $490,587,000 | +16.2% | 60,121 | +16.2% | 0.00% | 0.0% |
| Q1 2015 | $422,198,000 | -12.2% | 51,740 | -1.3% | 0.00% | 0.0% |
| Q4 2014 | $481,088,000 | -12.2% | 52,406 | -5.8% | 0.00% | 0.0% |
| Q3 2014 | $548,232,000 | -8.0% | 55,658 | +1.0% | 0.00% | -33.3% |
| Q2 2014 | $595,761,000 | – | 55,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |